<--GAT-->

Sickle Cell Trait Skews Hemoglobin A1c Results

by U.S. Medicine

May 19, 2017

PROVIDENCE, RI — Hemoglobin A1c might be underestimating glucose levels in a meaningful percentage of African-American and other patients.

A study published in JAMA points out that HbA1c readings are systematically too low in African-Americans with sickle cell trait, an inherited blood disorder that affects one million to three million Americans and 8% to 10% of African-Americans.1

To determine that, Brown University School of Public Health study retrospectively looked at a cohort of 4,620 African-Americans and found that, for any given fasting or two-hour glucose concentration, individuals with sickle cell trait (SCT) had significantly lower hemoglobin A1c values, 5.72% vs. 6.01%, than those without sickle cell trait.

Drawing from participants in the Coronary Artery Risk Development in Young Adults (CARDIA) study and the Jackson Heart Study (JHS), a study team including researchers from the Providence, RI, VAMC, focused on a cohort that was 61.3% female, mean age 52.3, with 7.9% having SCT.

Results indicate that HbA1c values were statistically significantly lower in those with SCT—5.72%—as opposed to those without—6.01%. Researchers pointed out that their findings were similar in models adjusted for key risk factors and in analyses using 2001 concurrent measures of two-hour glucose and HbA1c concentration for those with SCT vs. without—5.35% compared to 5.65%, a difference of -0.30%.

Furthermore, the study reported that the HbA1c difference by SCT was greater at higher fasting and two-hour glucose concentrations, while the prevalence of prediabetes and diabetes was statistically significantly lower among participants with SCT when defined using HbA1c values.

In 572 observations from participants with SCT and 6,877 observations from participants without SCT, rates were 29.2% vs. 48.6% for prediabetes and 3.8% vs. 7.3% for those with diabetes.

“Among African Americans from 2 large, well-established cohorts, participants with SCT had lower levels of HbA1c at any given concentration of fasting or 2-hour glucose compared with participants without SCT,” study authors concluded. “These findings suggest that HbA1c may systematically underestimate past glycemia in black patients with SCT and may require further evaluation.”

Lacy ME, Wellenius GA, Sumner AE, Correa A, Carnethon MR, Liem RI, Wilson JG, Sacks DB, Jacobs DR Jr, Carson AP, Luo X, Gjelsvik A, Reiner AP, Naik RP, Liu S, Musani SK, Eaton CB, Wu WC. Association of Sickle Cell Trait With


Comments are closed here.


Related Articles

Better Survival for NSCLC Patients Treated by Military Medicine

Does universal healthcare access provided by the MHS translate into improved patient outcomes for non-small cell lung cancer?

Increasing Usage of SSRIs for Dementia Symptoms

Emerging data has suggested effectiveness for selective serotonin reuptake inhibitors for treatment of behavioral and psychological symptoms of dementia.


U.S. Medicine Recommends


More From department of veterans affairs

Department of Veterans Affairs (VA)

Senate VA Committee Chair Vows to Pass 'Blue Water' Navy Benefits

Senate Committee on Veterans' Affairs Chairman Sen. Johnny Isakson (R-GA) vowed that addressing benefits for Blue Water Navy Veterans “is no longer going to be a question,” but that “how we do it is the only question.”

Department of Veterans Affairs (VA)

VHA Makes Progress in Improving Safety of Opioid Prescribing

VHA medical facilities should ensure that its providers are following three key opioid risk mitigation strategies, including conducting urine drug screening, a recent report recommended.

Department of Veterans Affairs (VA)

VA faces healthcare staffing shortages, barriers to hiring facility leaders

A facility-specific survey found that 138 of 140 VA facilities reported shortages of medical officers, with psychiatry and primary care positions being the most frequently listed.

Department of Veterans Affairs (VA)

Veteran nephrologist labors to improve ESRD treatment at VA

When Terrence O’Neil, MD, retired as chief of nephrology at the James H. Quillen VAMC in Johnson City in December 2016, he left in his wake decades of work treating kidney disease—nearly 35 years in the Air Force and DoD, plus 11 more at VA.

Department of Veterans Affairs (VA)

Committee approves bill to provide agent orange benefits to ‘blue water’ vets

A long sought-after bill that would make it easier for Blue Water Navy veterans to receive Agent Orange benefits has been passed by a key House of Representatives committee.

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up